Serveur d'exploration sur le lymphœdème

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.

Identifieur interne : 000341 ( Ncbi/Checkpoint ); précédent : 000340; suivant : 000342

Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.

Auteurs : M J Karkkainen [Finlande] ; R E Ferrell ; E C Lawrence ; M A Kimak ; K L Levinson ; M A Mctigue ; Kari Alitalo [Finlande] ; D N Finegold

Source :

RBID : pubmed:10835628

Descripteurs français

English descriptors

Abstract

Primary lymphoedema is a rare, autosomal dominant disorder that leads to a disabling and disfiguring swelling of the extremities and, when untreated, tends to worsen with time. Here we link primary human lymphoedema to the FLT4 locus, encoding vascular endothelial growth factor receptor-3 (VEGFR-3), in several families. All disease-associated alleles analysed had missense mutations and encoded proteins with an inactive tyrosine kinase, preventing downstream gene activation. Our study establishes that VEGFR-3 is important for normal lymphatic vascular function and that mutations interfering with VEGFR-3 signal transduction are a cause of primary lymphoedema.

DOI: 10.1038/75997
PubMed: 10835628


Affiliations:


Links toward previous steps (curation, corpus...)


Links to Exploration step

pubmed:10835628

Le document en format XML

<record>
<TEI>
<teiHeader>
<fileDesc>
<titleStmt>
<title xml:lang="en">Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.</title>
<author>
<name sortKey="Karkkainen, M J" sort="Karkkainen, M J" uniqKey="Karkkainen M" first="M J" last="Karkkainen">M J Karkkainen</name>
<affiliation wicri:level="4">
<nlm:affiliation>Molecular/Cancer Biology Laboratory, Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Helsinki, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Molecular/Cancer Biology Laboratory, Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Helsinki</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ferrell, R E" sort="Ferrell, R E" uniqKey="Ferrell R" first="R E" last="Ferrell">R E Ferrell</name>
</author>
<author>
<name sortKey="Lawrence, E C" sort="Lawrence, E C" uniqKey="Lawrence E" first="E C" last="Lawrence">E C Lawrence</name>
</author>
<author>
<name sortKey="Kimak, M A" sort="Kimak, M A" uniqKey="Kimak M" first="M A" last="Kimak">M A Kimak</name>
</author>
<author>
<name sortKey="Levinson, K L" sort="Levinson, K L" uniqKey="Levinson K" first="K L" last="Levinson">K L Levinson</name>
</author>
<author>
<name sortKey="Mctigue, M A" sort="Mctigue, M A" uniqKey="Mctigue M" first="M A" last="Mctigue">M A Mctigue</name>
</author>
<author>
<name sortKey="Alitalo, K" sort="Alitalo, K" uniqKey="Alitalo K" first="K" last="Alitalo">Kari Alitalo</name>
<affiliation>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Finegold, D N" sort="Finegold, D N" uniqKey="Finegold D" first="D N" last="Finegold">D N Finegold</name>
</author>
</titleStmt>
<publicationStmt>
<idno type="wicri:source">PubMed</idno>
<date when="2000">2000</date>
<idno type="RBID">pubmed:10835628</idno>
<idno type="pmid">10835628</idno>
<idno type="doi">10.1038/75997</idno>
<idno type="wicri:Area/PubMed/Corpus">004A66</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">004A66</idno>
<idno type="wicri:Area/PubMed/Curation">004A66</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">004A66</idno>
<idno type="wicri:Area/PubMed/Checkpoint">004A66</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">004A66</idno>
<idno type="wicri:Area/Ncbi/Merge">000341</idno>
<idno type="wicri:Area/Ncbi/Curation">000341</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">000341</idno>
</publicationStmt>
<sourceDesc>
<biblStruct>
<analytic>
<title xml:lang="en">Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.</title>
<author>
<name sortKey="Karkkainen, M J" sort="Karkkainen, M J" uniqKey="Karkkainen M" first="M J" last="Karkkainen">M J Karkkainen</name>
<affiliation wicri:level="4">
<nlm:affiliation>Molecular/Cancer Biology Laboratory, Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Helsinki, Finland.</nlm:affiliation>
<country xml:lang="fr">Finlande</country>
<wicri:regionArea>Molecular/Cancer Biology Laboratory, Ludwig Institute for Cancer Research, Haartman Institute, University of Helsinki, Helsinki</wicri:regionArea>
<orgName type="university">Université d'Helsinki</orgName>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
</affiliation>
</author>
<author>
<name sortKey="Ferrell, R E" sort="Ferrell, R E" uniqKey="Ferrell R" first="R E" last="Ferrell">R E Ferrell</name>
</author>
<author>
<name sortKey="Lawrence, E C" sort="Lawrence, E C" uniqKey="Lawrence E" first="E C" last="Lawrence">E C Lawrence</name>
</author>
<author>
<name sortKey="Kimak, M A" sort="Kimak, M A" uniqKey="Kimak M" first="M A" last="Kimak">M A Kimak</name>
</author>
<author>
<name sortKey="Levinson, K L" sort="Levinson, K L" uniqKey="Levinson K" first="K L" last="Levinson">K L Levinson</name>
</author>
<author>
<name sortKey="Mctigue, M A" sort="Mctigue, M A" uniqKey="Mctigue M" first="M A" last="Mctigue">M A Mctigue</name>
</author>
<author>
<name sortKey="Alitalo, K" sort="Alitalo, K" uniqKey="Alitalo K" first="K" last="Alitalo">Kari Alitalo</name>
<affiliation>
<country>Finlande</country>
<placeName>
<settlement type="city">Helsinki</settlement>
<region type="région" nuts="2">Uusimaa</region>
</placeName>
<orgName type="university">Université d'Helsinki</orgName>
</affiliation>
</author>
<author>
<name sortKey="Finegold, D N" sort="Finegold, D N" uniqKey="Finegold D" first="D N" last="Finegold">D N Finegold</name>
</author>
</analytic>
<series>
<title level="j">Nature genetics</title>
<idno type="ISSN">1061-4036</idno>
<imprint>
<date when="2000" type="published">2000</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc>
<textClass>
<keywords scheme="KwdEn" xml:lang="en">
<term>Alleles</term>
<term>Animals</term>
<term>Cell Line</term>
<term>Chromosomes, Human, Pair 5 (genetics)</term>
<term>Endothelial Growth Factors (pharmacology)</term>
<term>Enzyme Stability</term>
<term>Female</term>
<term>Genes, Dominant (genetics)</term>
<term>Half-Life</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Lymphedema (congenital)</term>
<term>Lymphedema (genetics)</term>
<term>Lymphedema (metabolism)</term>
<term>Male</term>
<term>Mice</term>
<term>Models, Molecular</term>
<term>Molecular Sequence Data</term>
<term>Mutation, Missense (genetics)</term>
<term>Pedigree</term>
<term>Phosphorylation (drug effects)</term>
<term>Protein Structure, Secondary</term>
<term>Receptor Protein-Tyrosine Kinases (chemistry)</term>
<term>Receptor Protein-Tyrosine Kinases (genetics)</term>
<term>Receptor Protein-Tyrosine Kinases (metabolism)</term>
<term>Receptors, Cell Surface (chemistry)</term>
<term>Receptors, Cell Surface (genetics)</term>
<term>Receptors, Cell Surface (metabolism)</term>
<term>Recombinant Fusion Proteins (chemistry)</term>
<term>Recombinant Fusion Proteins (genetics)</term>
<term>Recombinant Fusion Proteins (metabolism)</term>
<term>Signal Transduction (drug effects)</term>
<term>Transcriptional Activation (drug effects)</term>
<term>Transcriptional Activation (genetics)</term>
<term>Vascular Endothelial Growth Factor C</term>
<term>Vascular Endothelial Growth Factor Receptor-3</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr">
<term>Activation de la transcription ()</term>
<term>Activation de la transcription (génétique)</term>
<term>Allèles</term>
<term>Animaux</term>
<term>Chromosomes humains de la paire 5 (génétique)</term>
<term>Données de séquences moléculaires</term>
<term>Facteur de croissance endothéliale vasculaire de type C</term>
<term>Facteurs de croissance endothéliale (pharmacologie)</term>
<term>Femelle</term>
<term>Gènes dominants (génétique)</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Lymphoedème ()</term>
<term>Lymphoedème (génétique)</term>
<term>Lymphoedème (métabolisme)</term>
<term>Modèles moléculaires</term>
<term>Mutation faux-sens (génétique)</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Pedigree</term>
<term>Phosphorylation ()</term>
<term>Protéines de fusion recombinantes ()</term>
<term>Protéines de fusion recombinantes (génétique)</term>
<term>Protéines de fusion recombinantes (métabolisme)</term>
<term>Période</term>
<term>Récepteur-3 au facteur croissance endothéliale vasculaire</term>
<term>Récepteurs de surface cellulaire ()</term>
<term>Récepteurs de surface cellulaire (génétique)</term>
<term>Récepteurs de surface cellulaire (métabolisme)</term>
<term>Récepteurs à activité tyrosine kinase ()</term>
<term>Récepteurs à activité tyrosine kinase (génétique)</term>
<term>Récepteurs à activité tyrosine kinase (métabolisme)</term>
<term>Souris</term>
<term>Stabilité enzymatique</term>
<term>Structure secondaire des protéines</term>
<term>Transduction du signal ()</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="chemistry" xml:lang="en">
<term>Receptor Protein-Tyrosine Kinases</term>
<term>Receptors, Cell Surface</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en">
<term>Receptor Protein-Tyrosine Kinases</term>
<term>Receptors, Cell Surface</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="metabolism" xml:lang="en">
<term>Receptor Protein-Tyrosine Kinases</term>
<term>Receptors, Cell Surface</term>
<term>Recombinant Fusion Proteins</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="pharmacology" xml:lang="en">
<term>Endothelial Growth Factors</term>
</keywords>
<keywords scheme="MESH" qualifier="congenital" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="drug effects" xml:lang="en">
<term>Phosphorylation</term>
<term>Signal Transduction</term>
<term>Transcriptional Activation</term>
</keywords>
<keywords scheme="MESH" qualifier="genetics" xml:lang="en">
<term>Chromosomes, Human, Pair 5</term>
<term>Genes, Dominant</term>
<term>Lymphedema</term>
<term>Mutation, Missense</term>
<term>Transcriptional Activation</term>
</keywords>
<keywords scheme="MESH" qualifier="génétique" xml:lang="fr">
<term>Activation de la transcription</term>
<term>Chromosomes humains de la paire 5</term>
<term>Gènes dominants</term>
<term>Lymphoedème</term>
<term>Mutation faux-sens</term>
<term>Protéines de fusion recombinantes</term>
<term>Récepteurs de surface cellulaire</term>
<term>Récepteurs à activité tyrosine kinase</term>
</keywords>
<keywords scheme="MESH" qualifier="metabolism" xml:lang="en">
<term>Lymphedema</term>
</keywords>
<keywords scheme="MESH" qualifier="métabolisme" xml:lang="fr">
<term>Lymphoedème</term>
<term>Protéines de fusion recombinantes</term>
<term>Récepteurs de surface cellulaire</term>
<term>Récepteurs à activité tyrosine kinase</term>
</keywords>
<keywords scheme="MESH" qualifier="pharmacologie" xml:lang="fr">
<term>Facteurs de croissance endothéliale</term>
</keywords>
<keywords scheme="MESH" xml:lang="en">
<term>Alleles</term>
<term>Animals</term>
<term>Cell Line</term>
<term>Enzyme Stability</term>
<term>Female</term>
<term>Half-Life</term>
<term>Humans</term>
<term>Infant</term>
<term>Infant, Newborn</term>
<term>Male</term>
<term>Mice</term>
<term>Models, Molecular</term>
<term>Molecular Sequence Data</term>
<term>Pedigree</term>
<term>Protein Structure, Secondary</term>
<term>Vascular Endothelial Growth Factor C</term>
<term>Vascular Endothelial Growth Factor Receptor-3</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr">
<term>Activation de la transcription</term>
<term>Allèles</term>
<term>Animaux</term>
<term>Données de séquences moléculaires</term>
<term>Facteur de croissance endothéliale vasculaire de type C</term>
<term>Femelle</term>
<term>Humains</term>
<term>Lignée cellulaire</term>
<term>Lymphoedème</term>
<term>Modèles moléculaires</term>
<term>Mâle</term>
<term>Nourrisson</term>
<term>Nouveau-né</term>
<term>Pedigree</term>
<term>Phosphorylation</term>
<term>Protéines de fusion recombinantes</term>
<term>Période</term>
<term>Récepteur-3 au facteur croissance endothéliale vasculaire</term>
<term>Récepteurs de surface cellulaire</term>
<term>Récepteurs à activité tyrosine kinase</term>
<term>Souris</term>
<term>Stabilité enzymatique</term>
<term>Structure secondaire des protéines</term>
<term>Transduction du signal</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front>
<div type="abstract" xml:lang="en">Primary lymphoedema is a rare, autosomal dominant disorder that leads to a disabling and disfiguring swelling of the extremities and, when untreated, tends to worsen with time. Here we link primary human lymphoedema to the FLT4 locus, encoding vascular endothelial growth factor receptor-3 (VEGFR-3), in several families. All disease-associated alleles analysed had missense mutations and encoded proteins with an inactive tyrosine kinase, preventing downstream gene activation. Our study establishes that VEGFR-3 is important for normal lymphatic vascular function and that mutations interfering with VEGFR-3 signal transduction are a cause of primary lymphoedema.</div>
</front>
</TEI>
<affiliations>
<list>
<country>
<li>Finlande</li>
</country>
<region>
<li>Uusimaa</li>
</region>
<settlement>
<li>Helsinki</li>
</settlement>
<orgName>
<li>Université d'Helsinki</li>
</orgName>
</list>
<tree>
<noCountry>
<name sortKey="Ferrell, R E" sort="Ferrell, R E" uniqKey="Ferrell R" first="R E" last="Ferrell">R E Ferrell</name>
<name sortKey="Finegold, D N" sort="Finegold, D N" uniqKey="Finegold D" first="D N" last="Finegold">D N Finegold</name>
<name sortKey="Kimak, M A" sort="Kimak, M A" uniqKey="Kimak M" first="M A" last="Kimak">M A Kimak</name>
<name sortKey="Lawrence, E C" sort="Lawrence, E C" uniqKey="Lawrence E" first="E C" last="Lawrence">E C Lawrence</name>
<name sortKey="Levinson, K L" sort="Levinson, K L" uniqKey="Levinson K" first="K L" last="Levinson">K L Levinson</name>
<name sortKey="Mctigue, M A" sort="Mctigue, M A" uniqKey="Mctigue M" first="M A" last="Mctigue">M A Mctigue</name>
</noCountry>
<country name="Finlande">
<region name="Uusimaa">
<name sortKey="Karkkainen, M J" sort="Karkkainen, M J" uniqKey="Karkkainen M" first="M J" last="Karkkainen">M J Karkkainen</name>
</region>
<name sortKey="Alitalo, K" sort="Alitalo, K" uniqKey="Alitalo K" first="K" last="Alitalo">Kari Alitalo</name>
</country>
</tree>
</affiliations>
</record>

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/Ncbi/Checkpoint
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000341 | SxmlIndent | more

Ou

HfdSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd -nk 000341 | SxmlIndent | more

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Sante
   |area=    LymphedemaV1
   |flux=    Ncbi
   |étape=   Checkpoint
   |type=    RBID
   |clé=     pubmed:10835628
   |texte=   Missense mutations interfere with VEGFR-3 signalling in primary lymphoedema.
}}

Pour générer des pages wiki

HfdIndexSelect -h $EXPLOR_AREA/Data/Ncbi/Checkpoint/RBID.i   -Sk "pubmed:10835628" \
       | HfdSelect -Kh $EXPLOR_AREA/Data/Ncbi/Checkpoint/biblio.hfd   \
       | NlmPubMed2Wicri -a LymphedemaV1 

Wicri

This area was generated with Dilib version V0.6.31.
Data generation: Sat Nov 4 17:40:35 2017. Site generation: Tue Feb 13 16:42:16 2024